* BioRestorative Therapies Inc BRTX.OQ reported a
quarterly
adjusted loss of 13 cents per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -65 cents. The mean expectation of
two analysts for the quarter was for a loss of 43 cents per
share. Wall Street expected results to range from -51 cents
to -35 cents per share.
* Revenue rose 1,412.4% to $464.30 thousand from a year ago;
analysts expected $350.00 thousand.
* BioRestorative Therapies Inc's reported EPS for the
quarter was
a loss of 13 cents.
* The company reported a quarterly loss of $1.09 million.
* BioRestorative Therapies Inc shares had fallen by 5.7%
this
quarter and lost 5.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for BioRestorative
Therapies Inc is 12.00
This summary was machine generated from LSEG data November 13 at
02:25 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.43 -0.13 Beat
Jun. 30 2024 -0.56 -0.50 Beat
Mar. 31 2024 -0.52 -0.33 Beat
Dec. 31 2023 -0.69 -0.57 Beat